Cannabidiol, when extracted from the Cannabis sativa plant in its entirety, “cannot be regarded as a narcotic drug,” Europe’s highest court has ruled, in a judgment which is likely to have far-reaching ramifications for the region’s CBD market.
Delivering its long-awaited decision on a case brought against CBD vape marketer Kanavape by a French court, the European Court of Justice (CJEU) concluded that CBD extracted from the whole plant was not a drug within the meaning of the UN Single Convention on Narcotic Drugs given